Literature DB >> 21424267

Ecto-5'-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line.

Cláudia M B Andrade1, Patrícia L C Lopez, Bruno T Noronha, Márcia R Wink, Radovan Borojevic, Rogério Margis, Guido Lenz, Ana Maria O Battastini, Fátima C R Guma.   

Abstract

Ecto-5'-nucleotidase (eNT/CD73, E.C.3.1.3.5) is a glycosyl phosphatidylinositol (GPI)-linked cell-surface protein with several functions, including the local generation of adenosine from AMP, with the consequent activation of adenosine receptors and the salvaging of extracellular nucleotides. It also apparently functions independently of this activity, e.g., in the mediation of cell-cell adhesion. Liver fibrosis can be considered as a dynamic and integrated cellular response to chronic liver injury and the activation of hepatic stellate cells (HSCs) plays a role in the fibrogenic process. eNT/CD73 and adenosine are reported to play an important role in hepatic fibrosis in murine models. Knockdown of eNT/CD73 leads to an increase in mRNA expression of tissue non-specific alkaline phosphatase (TNALP), another AMP-degrading enzyme and thus no alteration is seen in the total ecto-AMPase activity of the cell. eNT/CD73 knockdown also leads to changes in the expression of collagen I and a clear alteration of cell migration. We suggest that eNT/CD73 protein expression controls cell migration and collagen expression in a mechanism independent of changes in nucleotide metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424267     DOI: 10.1007/s00441-011-1140-7

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  8 in total

Review 1.  New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors.

Authors:  Ross Corriden; Paul A Insel
Journal:  Purinergic Signal       Date:  2012-04-15       Impact factor: 3.765

2.  Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase/CD73 via specific SP1 and SMAD promoter elements.

Authors:  Michel Fausther; Nina Sheung; Yedidya Saiman; Meena B Bansal; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-16       Impact factor: 4.052

Review 3.  Purinergic signaling in scarring.

Authors:  Davide Ferrari; Roberto Gambari; Marco Idzko; Tobias Müller; Cristina Albanesi; Saveria Pastore; Gaetano La Manna; Simon C Robson; Bruce Cronstein
Journal:  FASEB J       Date:  2015-09-02       Impact factor: 5.191

4.  Altered fate of tendon-derived stem cells isolated from a failed tendon-healing animal model of tendinopathy.

Authors:  Yun Feng Rui; Pauline Po Yee Lui; Yin Mei Wong; Qi Tan; Kai Ming Chan
Journal:  Stem Cells Dev       Date:  2012-12-16       Impact factor: 3.272

5.  NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity.

Authors:  H Wang; S Lee; C Lo Nigro; L Lattanzio; M Merlano; M Monteverde; R Matin; K Purdie; N Mladkova; D Bergamaschi; C Harwood; N Syed; P Szlosarek; E Briasoulis; A McHugh; A Thompson; A Evans; I Leigh; C Fleming; G J Inman; E Hatzimichael; C Proby; T Crook
Journal:  Br J Cancer       Date:  2012-03-27       Impact factor: 7.640

6.  NT5E CpG island methylation is a favourable breast cancer biomarker.

Authors:  C Lo Nigro; M Monteverde; S Lee; L Lattanzio; D Vivenza; A Comino; N Syed; A McHugh; H Wang; C Proby; O Garrone; M Merlano; E Hatzimichael; E Briasoulis; O Gojis; C Palmieri; L Jordan; P Quinlan; A Thompson; T Crook
Journal:  Br J Cancer       Date:  2012-05-31       Impact factor: 7.640

7.  Unveiling the Role of Ecto-5'-Nucleotidase/CD73 in Astrocyte Migration by Using Pharmacological Tools.

Authors:  Marija Adzic; Nadezda Nedeljkovic
Journal:  Front Pharmacol       Date:  2018-03-01       Impact factor: 5.810

Review 8.  Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E.

Authors:  Theresa Kordaß; Wolfram Osen; Stefan B Eichmüller
Journal:  Front Immunol       Date:  2018-04-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.